Fulltext

Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative survival analysis

Koh PS 1 , Chan AC 2 , Cheung TT 3 , Chok KS 3 , Dai WC 3 , Poon RT 3 Show all authors , Lo CM 3

Affiliations 

  • 1 Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong Special Administrative Region; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 2 Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong Special Administrative Region. Electronic address: acchan@hku.hk
  • 3 Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong Special Administrative Region
HPB (Oxford), 2016 Jan;18(1):72-8.
PMID: 26776854 DOI: 10.1016/j.hpb.2015.07.005

Abstract

This study aims to assess if radiofrequency ablation (RFA) has any oncological superiority over transarterial chemoembolization (TACE) on post-hepatectomy recurrence.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications